PureTech Health Announces Board Role Change
Ticker: PTCHF · Form: 6-K · Filed: Jun 20, 2024 · CIK: 1782999
| Field | Detail |
|---|---|
| Company | Puretech Health PLC (PTCHF) |
| Form Type | 6-K |
| Filed Date | Jun 20, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-change, governance
Related Tickers: PRTC
TL;DR
PureTech Health (PRTC) announced a board role change on June 20, 2024.
AI Summary
On June 20, 2024, PureTech Health plc announced a change in a board role. The company, listed on LSE and Nasdaq under ticker PRTC, issued a press release detailing this board update.
Why It Matters
Changes in board roles can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a board role change and does not contain significant financial or operational news.
Key Players & Entities
- PureTech Health plc (company) — Registrant
- PRTC (company) — Stock ticker for PureTech Health plc
FAQ
What specific board role has changed at PureTech Health plc?
The filing states that PureTech Health plc announced a change in a board role, but the specific role is not detailed in this excerpt.
When was this change announced?
The change was announced on June 20, 2024.
What is the ticker symbol for PureTech Health plc?
The ticker symbol for PureTech Health plc is PRTC on both LSE and Nasdaq.
What form is this SEC filing?
This is a Form 6-K report.
Where is PureTech Health plc's principal executive office located?
The principal executive office is located at 6 Tide Street, Suite 400, Boston, Massachusetts 02210.
Filing Stats: 237 words · 1 min read · ~1 pages · Grade level 12.7 · Accepted 2024-06-20 07:30:26
Filing Documents
- d800509d6k.htm (6-K) — 9KB
- d800509dex991.htm (EX-99.1) — 10KB
- 0001193125-24-163983.txt ( ) — 20KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PURETECH HEALTH PLC Date: June 20, 2024 By: /s/ Bharatt Chowrira Name: Bharatt Chowrira Title: Chief Executive Officer